ArticlePreventive medicine reports2025
Twenty years population-based trends in prevalence, awareness, treatment, and control of hypertension in Geneva, Switzerland.
Article in Preventive medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Recognition, treatment, and control of hypertension in the Danish population-based Lolland-Falster Health Study.European journal of public health · 2026Article
- Age at menarche association with metabolic, reproductive, and sociodemographic factors: a population-based cross-sectional analysis using an outcome-wide framework in Geneva, Switzerland.European journal of public health · 2026Article
- Trends in Antihypertensive Medication Use and Blood Pressure Control in Adults Aged 66-79: Results of the National Examination Surveys DEGS1 and Study on Health of Older People Gesundheit 65.Journal of clinical hypertension (Greenwich, Conn.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Hypertension is a leading cause of cardiovascular disease and affects about 1.3 billion adults worldwide. Despite interventions, awareness and control remain suboptimal and might have worsened due to the COVID-19 pandemic. This population-based study examines 20-year trends in hypertension prevalence, awareness, treatment, and control in Geneva, Switzerland (2005-2023). Methods: This is a year-trends population-based study (Bus Sante) ongoing in Geneva, Switzerland. Data collected in this study were between 2005 and 2023. Hypertension trends and prevalence were stratified by sex, age, education, and income. Multivariable regression models adjusted for sociodemographic and health factors identified determinants of outcomes. Results: Overall, 11,278 individuals participated. Hypertension prevalence decreased from 38.9 % to 35.2 %, with greater reductions in individuals with primary education (-6.1 %) and low income (-6.1 %). Awareness remained stable with time. Uncontrolled hypertension decreased (44.9 % to 42.2 %, Conclusions: Hypertension prevalence and control improved overall, with reduced socioeconomic disparities. However, some groups remain at risk and primary care is essential for better screening, awareness, treatment, and control of hypertension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.